The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19
Abstract Background The observation of patients hospitalized for coronavirus disease (COVID-19) led us to note a lower prevalence of patients affected by chronic respiratory disease, in particular asthmatic patients, compared to the general population. Therefore, the aim of this paper is to evaluate...
Guardado en:
Autores principales: | Fabiana Furci, Marco Caminati, Gianenrico Senna, Sebastiano Gangemi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9b0b360605594d36b38cf0deb56612de |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
por: Priyadarshini Kachroo, et al.
Publicado: (2021) -
Small Airways Response to Bronchodilators in Adults with Asthma or COPD: A Systematic Review
por: Almeshari MA, et al.
Publicado: (2021) -
COPD: What the anaesthetist should know
por: M. L. Wong
Publicado: (2016) -
Effectiveness of Telemonitoring for Respiratory and Systemic Symptoms of Asthma and COPD: A Narrative Review
por: Esther Metting, et al.
Publicado: (2021) -
Racial Differences in Prevalence and Clinical Characteristics of Asthma–Chronic Obstructive Pulmonary Disease Overlap
por: Yong Suk Jo, et al.
Publicado: (2021)